Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus

Gastrointestinal Endoscopy

Volumn 71, Issue 4, 2010, Pages 697-703

  Badreddine, Rami J ^a   Prasad, Ganapathy A ^a   Wang, Kenneth K ^a   Wong Kee Song, Louis M ^a   Buttar, Navtej S ^a   Dunagan, Kelly T ^a   Lutzke, Lori S ^a   Borkenhagen, Lynn S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPORPHYRIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOTOFRIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RECURRENCE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; DRUG USE; DYSPLASIA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SMOKING; SQUAMOUS EPITHELIUM; TREATMENT INDICATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 77950189549     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.08.031     Document Type: Article

References (35)

1. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
2. Sampliner R.E., Faigel D., Fennerty M.B., et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53 (2001) 554-558
3. Pereira-Lima J.C., Busnello J.V., Saul C., et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 95 (2000) 1661-1668
4. Michopoulos S., Tsibouris P., Bouzakis H., et al. Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results. Gastrointest Endosc 50 (1999) 165-172
5. Van Laethem J.L., Cremer M., Peny M.O., et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 43 (1998) 747-751
6. Schulz H., Miehlke S., Antos D., et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 51 (2000) 659-663
7. Overholt B.F., Panjehpour M., and Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49 (1999) 1-7
8. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
9. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
10. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 132 (2007) 1226-1233
11. Overholt B.F., Wang K.K., Burdick J.S., et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 66 (2007) 460-468
12. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 57 (2008) 1200-1206
13. Peters F.P., Kara M.A., Rosmolen W.D., et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 61 (2005) 506-514
14. Conio M., Repici A., Cestari R., et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol 11 (2005) 6650-6655
15. Prasad G.A., Wang K.K., Buttar N.S., et al. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 65 (2007) 60-66
16. Krishnadath K.K., Wang K.K., Taniguchi K., et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 119 (2000) 624-630
17. Locke III G.R., Talley N.J., Fett S.L., et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106 (1999) 642-649
18. Kahrilas P.J., and Gupta R.R. Mechanisms of acid reflux associated with cigarette smoking. Gut 31 (1990) 4-10
19. Conio M., Filiberti R., Blanchi S., et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 97 (2002) 225-229
20. Caygill C.P., Johnston D.A., Lopez M., et al. Lifestyle factors and Barrett's esophagus. Am J Gastroenterol 97 (2002) 1328-1331
21. Gerson L.B., Shetler K., and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123 (2002) 461-467
22. Anderson L.A., Watson R.G., Murphy S.J., et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 13 (2007) 1585-1594
23. Olliver J.R., Hardie L.J., Dexter S., et al. DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 8 (2003) 509-521
24. Overholt B.F., Panjehpour M., and Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 58 (2003) 183-188
25. Wolfsen H.C., Woodward T.A., and Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77 (2002) 1176-1181
26. Wolfsen H.C., Hemminger L.L., Wallace M.B., et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther 20 (2004) 1125-1131
27. Bronner M.P., Overholt B.F., Taylor S.L., et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 136 (2009) 56-64 quiz 351-2
28. Hornick J.L., Mino-Kenudson M., Lauwers G.Y., et al. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 103 (2008) 38-47
29. Mino-Kenudson M., Ban S., Ohana M., et al. Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 31 (2007) 403-409
30. Overholt B.F., and Panjehpour M. Photodynamic therapy for Barrett's esophagus: clinical update. Am J Gastroenterol 91 (1996) 1719-1723
31. Hage M., Siersema P.D., Vissers K.J., et al. Molecular evaluation of ablative therapy of Barrett's oesophagus. J Pathol 205 (2005) 57-64
32. Pech O., May A., Rabenstein T., et al. Endoscopic resection of early oesophageal cancer. Gut 56 (2007) 1625-1634
33. Overholt B.F. Acid suppression and reepithelialization after ablation of Barrett's esophagus. Dig Dis 18 (2000) 232-239
34. Gossner L., Stolte M., Sroka R., et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 114 (1998) 448-455
35. Wang K.K. Photodynamic therapy of Barrett's esophagus. Gastrointest Endosc Clin N Am 10 (2000) 409-419